SYNMOSA BIOPHARMA CORPORATION

Synmosa Biopharma–A company dedicated in improving the quality of human life through superior and innovative pharmaceutical and health care products.
Synmosa Biopharma, an IPO listed in Taiwan OTC stock market, is a pharmaceutical company that develops, manufactures, markets, and distributes a broad range of pharmaceutical/healthcare products under the Synmosa trade mark. Synmosa also successfully markets and distributes many pharmaceutical products for several worldwide companies in the Asia Pacific Region.
Synmosa is majored in seven major therapeutic areas – cardiovascular, respiratory, central nervous system (CNS), NSAID, Hormone replacement treatment (HRT), Metabolic therapeutics and Oncology.
Synmosa was ranked as one of the top 20 fastest growing companies in Taiwan in 2003. Synmosa is one of the leading pharmaceutical companies through its quality products, innovation, creative marketing, and strong sales.
Following Synmosa's core values, we continuously strives for the better and healthier life by delivering safe and effective pharmaceutical products and health supplement products.


Our history
Synmosa Biopharma, formerly known as the Formosa Time Pharmaceuticals, was founded by Peter Lin in 1979. In the early days, the company started as a distributor for respiratory products for Orion Pharma in Taiwan. Mr. Lin's belief and dedication in prolonging and improving the quality life of human life through providing quality products led him to expand the company's vertical business line by acquiring Shin-Yuan chemical & Pharmaceutical Co. Ltd in 1992.
In 2001, for better utilization of company resources, Synmosa Biopharma was formed with the merger of Peter Trading Co. Ltd, Formosa Time Pharmaceutical Co Ltd, and Shin-Yuan Chemical & Pharmaceutical Co. Ltd
Synmosa Biopharma strongly believes in providing quality and innovative pharmaceutical and healthcare products to people, therefore we established our research center to create and study new components and delivery methods. In 2004, we established our low humidity health food plant in Shin-Chu industrial park.
In 2005, in order to improve our production capacity and to be able to supply the global market, we acquired Boehringer Ingelheim's Shin-Chu factory in Taiwan.
Know more about our Synmosa Plant - world-class factory
Synmosa's world-class factory, originally owned by Boehringer Ingelheim,was successfully passed International corporate GMP audits, authorities’ audit and validation audit by the government. This factory has been manufacturing and providing Boehringer Ingelheim's medical products in Taiwan and also to South Africa and Indonesia.
The Synmosa plant was built in 1985 by Boehringer Ingelheim as a manufacturing facility of solid dosage forms, liquids and MDI. It was expanded in 1990 and 1995. The factory is furnished with state-of the art equipment. It was transferred to Synmosa in Oct. 2005. Moreover, most of the well-trained talents by Beohringer Ingelheim continually work for Synmosa after the acquisition has made.